Molecularly targeted drugs for metastatic colorectal cancer
作者： Hua Yang , Ying-dong CHENG , Guo-qing CHEN , Zhi-cao ZHANG
DOI: 10.2147/DDDT.S52485
关键词:
摘要: The survival rate of patients with metastatic colorectal cancer (mCRC) has significantly improved with applications of molecularly targeted drugs, such as bevacizumab, and led to a …
paperity.org
researchgate.net 参考文章(83)
Giuseppe Aprile, Marianna Macerelli, Francesco Giuliani, Regorafenib for gastrointestinal malignancies : from preclinical data to clinical results of a novel multi-target inhibitor BioDrugs. ,vol. 27, pp. 213- 224 ,(2013) , 10.1007/S40259-013-0014-9
Sophie Whyte, Abdullah Pandor, Matt Stevenson, Bevacizumab for metastatic colorectal cancer: a NICE single technology appraisal. PharmacoEconomics. ,vol. 30, pp. 1119- 1132 ,(2012) , 10.2165/11597210-000000000-00000
Steven R. Alberts, Joleen M. Hubbard, Alternate dosing of cetuximab for patients with metastatic colorectal cancer Gastrointestinal cancer research : GCR. ,vol. 6, pp. 47- 55 ,(2013)
Ciardiello F, Pomatico G, Agrawal S, Pepe S, Bianco Ar, Caputo R, Tortora G, Mendelsohn J, Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast cancer cell growth. Clinical Cancer Research. ,vol. 5, pp. 875- 881 ,(1999)
M. S. Edwards, S. D. Chadda, Z. Zhao, B. L. Barber, D. P. Sykes, A systematic review of treatment guidelines for metastatic colorectal cancer. Colorectal Disease. ,vol. 14, ,(2012) , 10.1111/J.1463-1318.2011.02765.X
Scott M. Wilhelm, Jacques Dumas, Lila Adnane, Mark Lynch, Christopher A. Carter, Gunnar Schütz, Karl-Heinz Thierauch, Dieter Zopf, Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity International Journal of Cancer. ,vol. 129, pp. 245- 255 ,(2011) , 10.1002/IJC.25864
Hideharu Kimura, Kazuko Sakai, Tokuzo Arao, Tatsu Shimoyama, Tomohide Tamura, Kazuto Nishio, Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor Cancer Science. ,vol. 98, pp. 1275- 1280 ,(2007) , 10.1111/J.1349-7006.2007.00510.X
G. Cartenì, R. Fiorentino, L. Vecchione, B. Chiurazzi, C. Battista, Panitumumab a novel drug in cancer treatment. Annals of Oncology. ,vol. 18, ,(2007) , 10.1093/ANNONC/MDM218
T André, C Louvet, F Maindrault-Goebel, C Couteau, M Mabro, J.P Lotz, V Gilles-Amar, M Krulik, E Carola, V Izrael, A de Gramont, CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer European Journal of Cancer. ,vol. 35, pp. 1343- 1347 ,(1999) , 10.1016/S0959-8049(99)00150-1
Quincy Siu-Chung Chu, Aflibercept (AVE0005): an alternative strategy for inhibiting tumour angiogenesis by vascular endothelial growth factors Expert Opinion on Biological Therapy. ,vol. 9, pp. 263- 271 ,(2009) , 10.1517/14712590802666397